EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer.
Eur J Cancer. 2022 Jul 31:S0959-8049(22)00160-5. doi: 10.1016/j.ejca.2022.03.016. Online ahead of print.
Eur J Cancer. 2022.
PMID: 35922251